Key Antibodies for Cervical Cancer

Key Antibodies for Cervical Cancer are crucial in diagnosis, prognosis, and treatment monitoring. Antibodies like p16, Ki-67, and HPV-related markers are widely used to detect abnormal cell growth linked to cervical cancer. These biomarkers help doctors identify early stages, assess progression, and guide targeted therapies. Immunohistochemistry tests using these antibodies improve accuracy in detecting pre-cancerous and cancerous changes. With their role in precision medicine, Key Antibodies for Cervical Cancer provide hope for better outcomes and effective treatment strategies.